Kaile Science and Technology Co;Ltd.Hubei Logo

Kaile Science and Technology Co;Ltd.Hubei

600260.SS

(2.0)
Stock Price

0,47 CNY

-203.09% ROA

-357.2% ROE

-0.05x PER

Market Cap.

467.596.416,00 CNY

-90.73% DER

0% Yield

-898.78% NPM

Kaile Science and Technology Co;Ltd.Hubei Stock Analysis

Kaile Science and Technology Co;Ltd.Hubei Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Kaile Science and Technology Co;Ltd.Hubei Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (15.04%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-0.22x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-74%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

5 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (4) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

6 ROA

The stock's ROA (-8.12%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Kaile Science and Technology Co;Ltd.Hubei Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Kaile Science and Technology Co;Ltd.Hubei Technical Stock Analysis
# Analysis Recommendation

Kaile Science and Technology Co;Ltd.Hubei Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Kaile Science and Technology Co;Ltd.Hubei Revenue
Year Revenue Growth
1997 141.737.288
1998 173.684.817 18.39%
1999 261.326.481 33.54%
2000 306.580.836 14.76%
2001 430.840.855 28.84%
2002 363.007.125 -18.69%
2003 420.277.170 13.63%
2004 505.898.921 16.92%
2005 509.012.681 0.61%
2006 875.909.163 41.89%
2007 1.143.401.528 23.39%
2008 1.158.566.902 1.31%
2009 981.948.699 -17.99%
2010 1.627.097.939 39.65%
2011 1.532.820.380 -6.15%
2012 2.483.734.496 38.29%
2013 1.919.635.540 -29.39%
2014 1.743.091.404 -10.13%
2015 3.230.112.548 46.04%
2016 8.420.679.913 61.64%
2017 15.138.429.294 44.38%
2018 16.957.836.735 10.73%
2019 15.859.989.821 -6.92%
2020 8.499.587.353 -86.6%
2021 958.418.243 -786.83%
2022 681.281.340 -40.68%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Kaile Science and Technology Co;Ltd.Hubei Research and Development Expenses
Year Research and Development Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 25.452.227 100%
2016 67.730.610 62.42%
2017 111.277.687 39.13%
2018 557.717.193 80.05%
2019 529.028.388 -5.42%
2020 303.282.137 -74.43%
2021 108.680.489 -179.06%
2022 36.047.096 -201.5%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Kaile Science and Technology Co;Ltd.Hubei General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 4.373.966
1998 6.149.517 28.87%
1999 6.297.953 2.36%
2000 7.057.193 10.76%
2001 7.326.198 3.67%
2002 6.933.704 -5.66%
2003 17.301.803 59.92%
2004 15.654.687 -10.52%
2005 12.371.984 -26.53%
2006 48.718.300 74.61%
2007 35.070.582 -38.92%
2008 66.168.360 47%
2009 51.807.541 -27.72%
2010 27.024.636 -91.7%
2011 25.356.943 -6.58%
2012 29.936.656 15.3%
2013 24.995.526 -19.77%
2014 30.941.042 19.22%
2015 35.768.187 13.5%
2016 51.667.393 30.77%
2017 66.992.892 22.88%
2018 69.751.755 3.96%
2019 77.951.635 10.52%
2020 80.310.736 2.94%
2021 74.428.781 -7.9%
2022 201.245.400 63.02%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Kaile Science and Technology Co;Ltd.Hubei EBITDA
Year EBITDA Growth
1997 34.212.100
1998 46.483.659 26.4%
1999 80.557.448 42.3%
2000 97.768.091 17.6%
2001 121.834.221 19.75%
2002 92.862.401 -31.2%
2003 85.482.958 -8.63%
2004 123.625.254 30.85%
2005 100.737.266 -22.72%
2006 176.847.667 43.04%
2007 193.115.694 8.42%
2008 134.811.939 -43.25%
2009 218.957.098 38.43%
2010 148.568.590 -47.38%
2011 194.582.957 23.65%
2012 398.234.302 51.14%
2013 282.289.323 -41.07%
2014 270.651.424 -4.3%
2015 376.752.778 28.16%
2016 529.478.008 28.84%
2017 1.387.623.538 61.84%
2018 1.697.653.704 18.26%
2019 1.329.674.499 -27.67%
2020 825.947.205 -60.99%
2021 -8.145.258.687 110.14%
2022 -181.948.555 -4376.68%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Kaile Science and Technology Co;Ltd.Hubei Gross Profit
Year Gross Profit Growth
1997 48.484.106
1998 61.320.632 20.93%
1999 86.723.964 29.29%
2000 95.923.768 9.59%
2001 134.931.166 28.91%
2002 88.588.070 -52.31%
2003 96.633.288 8.33%
2004 120.228.711 19.63%
2005 84.144.705 -42.88%
2006 252.375.628 66.66%
2007 236.249.867 -6.83%
2008 263.798.671 10.44%
2009 224.807.766 -17.34%
2010 333.036.236 32.5%
2011 398.152.175 16.35%
2012 743.434.988 46.44%
2013 525.382.837 -41.5%
2014 414.383.725 -26.79%
2015 550.725.424 24.76%
2016 850.236.805 35.23%
2017 1.752.527.864 51.49%
2018 2.562.957.342 31.62%
2019 2.074.157.093 -23.57%
2020 1.604.571.665 -29.27%
2021 103.577.100 -1449.16%
2022 142.606.264 27.37%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Kaile Science and Technology Co;Ltd.Hubei Net Profit
Year Net Profit Growth
1997 26.988.135
1998 36.441.787 25.94%
1999 54.324.009 32.92%
2000 67.824.330 19.9%
2001 90.506.409 25.06%
2002 53.341.595 -69.67%
2003 42.755.060 -24.76%
2004 60.624.032 29.48%
2005 46.294.368 -30.95%
2006 83.933.202 44.84%
2007 94.895.007 11.55%
2008 67.728.326 -40.11%
2009 142.865.349 52.59%
2010 45.029.972 -217.27%
2011 63.010.561 28.54%
2012 189.529.367 66.75%
2013 78.606.521 -141.11%
2014 47.516.542 -65.43%
2015 119.612.656 60.27%
2016 182.229.579 34.36%
2017 739.582.919 75.36%
2018 904.731.513 18.25%
2019 873.634.371 -3.56%
2020 453.752.325 -92.54%
2021 -8.614.084.553 105.27%
2022 -302.906.387 -2743.81%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Kaile Science and Technology Co;Ltd.Hubei Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 0 0%
2021 -9 100%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Kaile Science and Technology Co;Ltd.Hubei Free Cashflow
Year Free Cashflow Growth
1999 8.173.650
2000 -36.138.030 122.62%
2001 -6.805.599 -431%
2002 -97.305.362 93.01%
2003 36.723.700 364.97%
2004 -203.392.216 118.06%
2005 -161.460.638 -25.97%
2006 -59.546.844 -171.15%
2007 -96.437.759 38.25%
2008 -376.349.049 74.38%
2009 -65.022.360 -478.8%
2010 -57.359.171 -13.36%
2011 -920.974.377 93.77%
2012 -19.329.133 -4664.7%
2013 -99.387.964 80.55%
2014 -188.787.411 47.35%
2015 888.445.691 121.25%
2016 -1.736.483.375 151.16%
2017 26.287.263 6705.8%
2018 1.559.158.080 98.31%
2019 1.748.837.799 10.85%
2020 2.016.787.949 13.29%
2021 -647.776.643 411.34%
2022 -75.866.243 -753.84%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Kaile Science and Technology Co;Ltd.Hubei Operating Cashflow
Year Operating Cashflow Growth
1999 52.816.905
2000 93.893.663 43.75%
2001 41.738.737 -124.96%
2002 -65.570.406 163.65%
2003 83.688.516 178.35%
2004 -101.757.098 182.24%
2005 -139.047.740 26.82%
2006 14.549.542 1055.68%
2007 -17.636.972 182.49%
2008 -307.047.536 94.26%
2009 31.356.439 1079.22%
2010 1.424.673 -2100.96%
2011 -883.764.558 100.16%
2012 197.781.271 546.84%
2013 209.749.705 5.71%
2014 -82.041.222 355.66%
2015 956.866.385 108.57%
2016 -1.638.662.081 158.39%
2017 156.959.693 1144%
2018 1.637.067.698 90.41%
2019 1.771.174.265 7.57%
2020 2.042.920.354 13.3%
2021 -635.303.152 421.57%
2022 -75.726.597 -738.94%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Kaile Science and Technology Co;Ltd.Hubei Capital Expenditure
Year Capital Expenditure Growth
1999 44.643.255
2000 130.031.693 65.67%
2001 48.544.337 -167.86%
2002 31.734.956 -52.97%
2003 46.964.816 32.43%
2004 101.635.117 53.79%
2005 22.412.898 -353.47%
2006 74.096.387 69.75%
2007 78.800.787 5.97%
2008 69.301.513 -13.71%
2009 96.378.799 28.09%
2010 58.783.844 -63.95%
2011 37.209.819 -57.98%
2012 217.110.404 82.86%
2013 309.137.669 29.77%
2014 106.746.190 -189.6%
2015 68.420.695 -56.01%
2016 97.821.294 30.06%
2017 130.672.429 25.14%
2018 77.909.617 -67.72%
2019 22.336.465 -248.8%
2020 26.132.404 14.53%
2021 12.473.492 -109.5%
2022 139.646 -8832.22%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Kaile Science and Technology Co;Ltd.Hubei Equity
Year Equity Growth
2002 881.991.212
2003 924.266.305 4.57%
2004 984.879.421 6.15%
2005 1.032.339.825 4.6%
2006 1.116.273.026 7.52%
2007 1.586.548.887 29.64%
2008 1.361.618.003 -16.52%
2009 1.488.096.087 8.5%
2010 1.455.574.666 -2.23%
2011 1.482.123.481 1.79%
2012 1.684.084.097 11.99%
2013 1.766.823.096 4.68%
2014 1.745.242.197 -1.24%
2015 2.831.569.855 38.36%
2016 2.985.181.800 5.15%
2017 4.702.384.987 36.52%
2018 5.538.774.362 15.1%
2019 6.183.146.254 10.42%
2020 6.638.466.978 6.86%
2021 -1.815.383.801 465.68%
2022 -2.112.437.614 14.06%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Kaile Science and Technology Co;Ltd.Hubei Assets
Year Assets Growth
2002 1.020.014.641
2003 1.186.163.247 14.01%
2004 1.365.318.896 13.12%
2005 1.597.829.639 14.55%
2006 1.521.059.824 -5.05%
2007 2.430.335.162 37.41%
2008 2.362.236.086 -2.88%
2009 3.190.368.113 25.96%
2010 3.350.183.744 4.77%
2011 4.170.819.095 19.68%
2012 5.291.808.991 21.18%
2013 5.487.023.438 3.56%
2014 5.596.355.133 1.95%
2015 7.746.127.456 27.75%
2016 13.905.471.745 44.29%
2017 18.618.192.583 25.31%
2018 21.737.301.040 14.35%
2019 13.683.522.104 -58.86%
2020 12.573.799.080 -8.83%
2021 4.318.991.638 -191.13%
2022 3.806.198.517 -13.47%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Kaile Science and Technology Co;Ltd.Hubei Liabilities
Year Liabilities Growth
2002 138.023.429
2003 253.095.657 45.47%
2004 351.243.374 27.94%
2005 524.197.007 32.99%
2006 392.512.629 -33.55%
2007 829.184.156 52.66%
2008 983.631.378 15.7%
2009 1.686.974.564 41.69%
2010 1.814.063.447 7.01%
2011 2.559.132.546 29.11%
2012 3.404.139.769 24.82%
2013 3.531.455.008 3.61%
2014 3.738.583.481 5.54%
2015 4.768.580.523 21.6%
2016 10.547.211.564 54.79%
2017 13.499.415.364 21.87%
2018 15.802.043.542 14.57%
2019 7.286.432.603 -116.87%
2020 5.737.978.714 -26.99%
2021 6.134.852.196 6.47%
2022 5.931.659.115 -3.43%

Kaile Science and Technology Co;Ltd.Hubei Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.96
Net Income per Share
-8.65
Price to Earning Ratio
-0.05x
Price To Sales Ratio
0.49x
POCF Ratio
-0.74
PFCF Ratio
-0.72
Price to Book Ratio
-0.26
EV to Sales
1.79
EV Over EBITDA
-0.21
EV to Operating CashFlow
-2.7
EV to FreeCashFlow
-2.65
Earnings Yield
-18.4
FreeCashFlow Yield
-1.39
Market Cap
0,47 Bil.
Enterprise Value
1,71 Bil.
Graham Number
18.84
Graham NetNet
-5.18

Income Statement Metrics

Net Income per Share
-8.65
Income Quality
0.07
ROE
-3.57
Return On Assets
-1.99
Return On Capital Employed
12.47
Net Income per EBT
1.02
EBT Per Ebit
1.03
Ebit per Revenue
-8.59
Effective Tax Rate
-0.02

Margins

Sales, General, & Administrative to Revenue
0.08
Research & Developement to Revenue
0.11
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.11
Operating Profit Margin
-8.59
Pretax Profit Margin
-8.82
Net Profit Margin
-8.99

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.01
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.64
Free CashFlow per Share
-0.65
Capex to Operating CashFlow
0.02
Capex to Revenue
-0.01
Capex to Depreciation
-0.15
Return on Invested Capital
49.82
Return on Tangible Assets
-2.03
Days Sales Outstanding
0
Days Payables Outstanding
283.85
Days of Inventory on Hand
294.34
Receivables Turnover
958418243
Payables Turnover
1.29
Inventory Turnover
1.24
Capex per Share
-0.01

Balance Sheet

Cash per Share
0,64
Book Value per Share
-1,82
Tangible Book Value per Share
-1.9
Shareholders Equity per Share
-1.82
Interest Debt per Share
1.74
Debt to Equity
-0.91
Debt to Assets
0.38
Net Debt to EBITDA
-0.15
Current Ratio
0.59
Tangible Asset Value
-1,89 Bil.
Net Current Asset Value
-3,18 Bil.
Invested Capital
-0.91
Working Capital
-2,03 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,00 Bil.
Average Payables
1,28 Bil.
Average Inventory
1241983788.5
Debt to Market Cap
3.52

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Kaile Science and Technology Co;Ltd.Hubei Dividends
Year Dividends Growth
2001 0
2002 0 0%
2009 0 0%
2014 0 0%
2016 0 0%
2018 0 0%
2019 0 0%

Kaile Science and Technology Co;Ltd.Hubei Profile

About Kaile Science and Technology Co;Ltd.Hubei

Kaile Science and Technology Co;Ltd.Hubei offers communication equipment software and hardware for the information industry in China. It offers optical fiber, optical cable, data cable, quantum communication data link, military and civilian intelligent command terminal, radio frequency coaxial cable, optoelectronic components, and other optoelectronic communication products, as well as pipe, profiles, and geosynthetic products. The company also provides autonomous controllable computing platforms; wines; medical platforms; and real estate brand communication, sales, investment, operation, and big data support services under the Haofangbu, Haofang.com, Bojun Star Hotel, and Kaile Plaza brands. In addition, it designs and manufactures mobile smart phones and tablet computers. The company was founded in 1982 and is based in Jingzhou, China.

CEO
Mr. Shengjun Ma
Employee
906
Address
Kaile Industrial City
Jingzhou, 434300

Kaile Science and Technology Co;Ltd.Hubei Executives & BODs

Kaile Science and Technology Co;Ltd.Hubei Executives & BODs
# Name Age
1 Mr. Yong Jun Zhang
Deputy Gen. Mang.
70
2 Ms. Lian Chun Liu
Financial Director
70
3 Ms. Zhang Yang
Deputy Gen. Mang.
70
4 Mr. Zhang Jian
Deputy Gen. Mang.
70
5 Mr. Jun Lin Zhu
Vice Chairman & GM
70
6 Mr. Xiao Cheng Zhao
Deputy Gen. Mang.
70
7 Mr. Xiao Ming Zhao
Deputy Gen. Mang.
70
8 Mr. Wei Huang
Chief Engineer
70
9 Mr. Hang Lu
Deputy Gen. Mang.
70
10 Mr. Zhi Jun Wan
Deputy Gen. Mang.
70
11 Mr. Shengjun Ma
Gen. Mang. and Director
70
12 Mr. Han Ping
Director & Board Sec.
70
13 Mr. Zhi Liang Fan
Chief Engineer
70
14 Mr. Zhong Bing Huang
Deputy Gen. Mang. and Director
70
15 Mr. He Ping Duan
Deputy Gen. Mang.
70
16 Mr. Xiao Cheng Zhao
Deputy Gen. Mang.
70
17 Mr. Ji Xiao Wang
Deputy Gen. Mang.
70
18 Mr. Xiao Ming Zhao
Deputy Gen. Mang.
70

Kaile Science and Technology Co;Ltd.Hubei Competitors